Walpar Nutrition, a company in the Pharmaceuticals industry, reported revenue of ₹41 crore and net profit of ₹1.74 crore for the September 2026 quarter.
Walpar Nutrition (NSE: WALPAR-SM) closed at ₹20.90 on 20 Nov 2026, down 49.8% over the past year. Its market capitalisation is ₹20 crore and it trades at 8.1 times earnings.
Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.